The condition can lead to hepatitis, fibrosis, cirrhosis and liver failure. 這種情況可能導致肝炎，肝纖維化，肝硬化和肝功能衰竭。
Patients showing fibrosis progression were compared with nonprogressors for baseline and follow-up parameters. 隨訪(fǎng)期間患者與基線(xiàn)時(shí)無(wú)應答者相比較顯示出肝纖維化進(jìn)展。
滬公網(wǎng)安備 31011502000490號
電信業(yè)務(wù)許可證編號：滬B2-20190700
